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Abstract
Human interferon (IFN)-inducible IFI16 protein, an innate immune sensor of intracellular DNA, modulates various cell
functions, however, its role in regulating virus growth remains unresolved. Here, we adopt two approaches to investigate
whether IFI16 exerts pro- and/or anti-viral actions. First, the IFI16 gene was silenced using specific small interfering RNAs
(siRNA) in human embryo lung fibroblasts (HELF) and replication of DNA and RNA viruses evaluated. IFI16-knockdown
resulted in enhanced replication of Herpesviruses, in particular, Human Cytomegalovirus (HCMV). Consistent with this, HELF
transduction with a dominant negative form of IFI16 lacking the PYRIN domain (PYD) enhanced the replication of HCMV.
Second, HCMV replication was compared between HELFs overexpressing either the IFI16 gene or the LacZ gene. IFI16
overexpression decreased both virus yield and viral DNA copy number. Early and late, but not immediate-early, mRNAs and
proteins were strongly down-regulated, thus IFI16 may exert its antiviral effect by impairing viral DNA synthesis. Constructs
with the luciferase reporter gene driven by deleted or site-specific mutated forms of the HCMV DNA polymerase (UL54)
promoter demonstrated that the inverted repeat element 1 (IR-1), located between 254 and 243 relative to the
transcription start site, is the target of IFI16 suppression. Indeed, electrophoretic mobility shift assays and chromatin
immunoprecipitation demonstrated that suppression of the UL54 promoter is mediated by IFI16-induced blocking of Sp1-
like factors. Consistent with these results, deletion of the putative Sp1 responsive element from the HCMV UL44 promoter
also relieved IFI16 suppression. Together, these data implicate IFI16 as a novel restriction factor against HCMV replication
and provide new insight into the physiological functions of the IFN-inducible gene IFI16 as a viral restriction factor.
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Introduction
Human Cytomegalovirus (HCMV) is a b-Herpesvirus that
commonly and persistently infects humans [1–2]. HCMV does not
constitute a serious threat to immunocompetent individuals, but
causes life-threatening complications in individuals with sup-
pressed immune systems, such as patients with AIDS, cancer
patients undergoing chemotherapy, and organ transplant recipi-
ents treated with immunosuppressants [3]. Viral gene expression
in HCMV undergoes sequential regulation, which leads to the
occurrence of induction and repression cycles in the immediate
early (IE), early (E), and late (L) phases of viral replication. IE1 and
IE2 induce the expression of early protein, mediate G1/S cell
cycle arrest and host replication shut-off [4–5].
Many mammals, including humans, are equipped with genes
encoding so-called ‘‘restriction factors’’ that provide considerable
resistance to viral infection [6]. Such intrinsic immune mecha-
nisms are highly important as they provide an antiviral frontline
defense mediated by constitutively expressed proteins, already
present and active before a virus enters a cell [7–8]. These intrinsic
immune mechanisms were initially discovered as being active
against retroviruses and involve the APOBEC3 class of cytidine
deaminases, a large family of proteins termed the TRIM family,
and tetherin, an interferon-inducible protein whose expression
blocks the release of HIV-1. It has recently emerged, however, that
such intrinsic immune mechanisms are also active against other
viruses, such as Vesicular Stomatitis Virus, Filoviruses, Influenza
Virus, and Hepatitis C Virus [9]. Moreover, four cellular proteins
– promyelocitic leukemia protein (PML), hDaxx, Sp100 [10], and
viperin – have been identified as restriction factors involved in
mediating intrinsic immunity against HCMV infection [11]. PML
and hDaxx are components of a subnuclear structure known as
nuclear domain 10 (ND10) or PML nuclear bodies. Direct
evidence for their antiviral role has been obtained from infection
studies using cells devoid of intact ND10. Primary human
fibroblasts depleted of PML using small interfering RNA (siRNA)
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a result of an augmented immediate-early (IE) gene expression
[12]. hDaxx represses HCMV IE gene expression [11,13,14] and
replication [12] through the action of a histone deacetylase
(HDAC), thereby inducing a transcriptionally inactive chromatin
state around the major IE enhancer/promoter (MIEP) of HCMV
[13–14]. Together, these findings revealed that ND10 proteins,
PML and hDaxx, act as cellular restriction factors that are able to
induce silencing of HCMV gene expression, thus controlling virus
replication.
Of the various interferon-inducible proteins, the p200 family of
proteins, now designated the PYHIN family, consists of a group of
homologous human and mouse proteins that have an N-terminal
PYRIN domain (PYD) and one or two partially conserved 200
amino acid long C-terminal domains (HIN domain). These
proteins display multifaceted activity due to their ability to bind
to various target proteins (e.g. transcription factors, signaling
proteins, and tumor suppressor proteins) and modulate different
cell functions. Increasing evidence supports a role for these
proteins as regulators of various cell functions, including
proliferation, differentiation, apoptosis, senescence, and inflam-
masome assembly, as well as in the control of organ transplants
(reviewed in [15–16]). More recently, two members of the PYHIN
family, namely AIM2 and IFI16, have been shown to bind to and
function as pattern recognition receptors (PRR) of virus-derived
intracellular DNA [17–20]. In particular, IFI16 has been shown to
interact with the adaptor molecule ASC and procaspase-1 to form
a functional inflammasome during Kaposi Sarcoma-Associated
Herpesvirus (KSHV) infection. KSHV gene expression is required
for inflammasome activation and IFI16 colocalizes with the
KSHV genome in infected cell nuclei [20]. Moreover, the
induction of IRF3 and NF-kB-dependent genes by HSV-1
infection of RAW264.7 cells is strongly impaired by siRNA
specific for p204, the mouse ortholog of IFI16 [19]. However,
although many different functions have been ascribed to these
proteins, their roles as antiviral restriction factors have yet to be
investigated, whilst such roles have long been established for other
IFN-inducible proteins, such as, PKR, 29-59 oligoadenylate
synthetase, and MxA [21–22].
In the present study, by either silencing or overexpressing the
IFI16 protein, we demonstrate for the first time that IFI16 acts as a
restriction factor for Human Cytomegalovirus (HCMV) replica-
tion. Transfection and electrophoretic mobility shift assay (EMSA)
experiments, performed using nuclear extracts from HCMV
infected cells, showed that the promoter of the DNA polymerase
gene (UL54) is the target of IFI16-induced viral suppression.
Finally, biochemical and immunochemical analyses reveal that
IFI16 inhibits DNA polymerase gene activity by preventing the
binding of transcription factor Sp1 to the 254/243 IR-1
promoter element.
Results
IFI16 protein specifically inhibits replication of
Herpesviruses but not of other viruses
To determine the effects of IFI16 silencing on virus replication,
IFI16-knockdown HELFs were infected with HCMV (AD169
strain), HSV-1, HSV-2, ADV, or VSV at an MOI of 0.05. As
shown in Figure 1A, the replication of HSV at 48 hpi and of
HCMV at 144 hpi was increased in IFI16-silenced HELFs. In
contrast, the replication of a clinical isolate of Adenovirus and that
of a VSV laboratory strain was not significantly affected
(Figure 1A). Consistent with previous data, Western blot analysis
confirmed that the electroporation of HELFs with four IFI16
specific siRNAs knocked IFI16 expression down by more than
90% for at least 14 days (Figure 1B).
To provide further evidence supporting the physiological
relevance of IFI16 in the control of Herpesvirus replication, we
generated HELFs overexpressing wild type (wt) or mutated IFI16
proteins using recombinant lentiviral vectors, or the LacZ gene as
a control. These V5-tagged IFI16 proteins bear deletions between
residues 1–83 (DPYDIFI16, indicated as DDIFI16) or between
residues 515–710 (DHIN-BIFI16, indicated as DBIFI16), respec-
tively, and thus held the potential to inhibit the activity of the
endogenous counterpart. Expression of the exogenous V5-tagged
IFI16 was confirmed using anti-V5 antibodies that recognized
proteins of about 82 kDa (wtIFI16), 70 kDa (DDIFI16) or 60 kDa
(DBIFI16), and 121 kDa in the control (LacZ) (Figure 2A).When
overexpressed in stably-transfected cell lines, both DDIFI16 and
DBIFI16 decreased the ability of full length IFI16 (AdV IFI16) to
induce proinflammatory molecules and to trigger caspase-3 and 7
activity (Figure S1 panel A and B respectively). These results
suggest that the mutant IFI16 proteins may behave as dominant
negative (dn) towards the endogenous counterpart.
The effects of DDIFI16 and DBIFI16 deleted mutants on viral
growth were then examined by comparing the ability of HELFs
transfected with either the mutated forms of IFI16 or the full
length protein to support HCMV complete replication. In line
with the results of the previous experiments that used siRNAs to
silence IFI16, expression of the DDIFI16 protein substantially
increased the extent of HCMV replication (Figure 2B) at both the
MOIs used. Expression of DBIFI16 showed a level of virus yield
similar to that observed in HELFs transduced with the LacZ gene,
whereas overexpression of full length IFI16 reduced virus
replication. Altogether, these results demonstrate that reducing
IFI16 activity with DDIFI16 consistently increases the rate of
HCMV replication, whereas overexpression of the full length
protein down-regulates its replication, implying IFI16 as a novel
restriction factor in the replicative cycle of Herpesviruses.
Author Summary
Only recently, intrinsic cellular-based defense mechanisms
which give cells the capacity to resist pathogens have
been discovered as an essential component of immunity.
However, unlike the innate and adaptive branches of the
immune system, intrinsic immune defenses are mediated
by cellular restriction factors that are constitutively
expressed and active even before a pathogen enters the
cell. The protein family HIN-200 may act as sensors of
foreign DNA and modulate various functions such as
growth, apoptosis, and senescence. Here we show that, in
the absence of functional IFI16, the replication of some
Herpesviruses and in particular of Human Cytomegalovirus
(HCMV) is significantly enhanced. Accordingly, IFI16
overexpression strongly inhibited HCMV replication. Accu-
mulation of viral DNA copies was down-regulated along
with expression of early and late viral gene expression
suggesting that IFI16 inhibits viral DNA synthesis. Using
transient transfection, luciferase, gel shift assay, and
chromatin immunoprecipitation, we demonstrate that
IFI16 suppresses the transcriptional activity of the viral
DNA polymerase gene (UL54) and the UL44 gene, also
required for viral DNA synthesis. The finding that the
nuclear DNA sensor IFI16 controls virus growth represents
an important step forward in understanding the intrinsic
mechanisms that drive viral infections sustained by DNA
viruses such as Herpesviruses.
The DNA Sensor IFI16 Restricts HCMV Replication
PLoS Pathogens | www.plospathogens.org 2 January 2012 | Volume 8 | Issue 1 | e1002498Figure 1. IFI16 protein is a negative regulator of Herpesvirus replication. A) HELFs were electroporated with a mixture of four different small
interfering RNAs (siRNA IFI16), scrambled control siRNA (siRNA ctrl), or left not electroporated (NE), and then infected with the indicated viruses at a
multiplicity of 0.05 PFU/cell. Cell-free supernatants were harvested on the indicated hours post infection (hpi) and virus amounts determined by plaque
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Cristea et al. [23] and those previously published by Rolle et al. [24]
with the IFI16 mouse homolog Ifi204, who found that knocking
down IFI16 or Ifi204 expression caused a delay in the accumulation
of infectious CMV progeny, but no net reduction in its replication.
To explain these discrepancies, we performed kinetic experiments in
which IFI16-knockdown HELFs (i.e. IFI16-silenced using siRNA)
were infected with HCMV at two different MOI (0.05 and 1,
respectively) and the viral yield evaluated at different time points post
infection (hpi). At 96 hpi, the number of infectious particles measured
in the IFI16-knockdown cells (siRNA IFI16) infected at an MOI of
0.05 was actually decreased compared to that of HELFs electropo-
rated with control siRNA (siRNA ctrl) or left not electroporated (NE)
(Figure 1C, left panel). At 120 hpi, the number of plaque forming
units (PFU) in the absence of IFI16 expression started to be higher
than that observed in the control HELF cultures electroporated with
siRNA ctrl or sham-electroporated. In contrast, at 144 hpi, the
accumulation of HCMV progeny exhibited an ,3- fold increased
yield in the absence of IFI16 expression. At the higher MOI, no
differences in virus yield were observed irrespective of the level of
IFI16 expression (Figure 1C, right panel). Thus, in line with the
results of Cristea et al. [23] and Rolle et al. [24], our findings indicate
that Herpesvirus replication, and in particular that of HCMV, may
be impaired by IFI16 silencing in the first hours after infection at the
lower MOI, but as virus replication progresses this impairment
becomes lost as shown by increased viral yields compared to controls
at the later time points p.i. At higher MOI, however, the relevance of
IFI16 in the control of HCMV replication appears to be less.
HCMV is able to replicate in vivo and in vitro in many different
host cells including vascular endothelial cells, epithelial cells,
connective tissue cells, hepatocytes, and various leukocyte
populations (reviewed in [25]). Since fibroblasts are not the most
important target cells in vivo, we evaluated the effect of IFI16
silencing on HCMV replication in human umbilical vein
endothelial cells (HUVEC), a cell system considered to be more
pertinent for HCMV replication in vivo. For this purpose, HUVEC
were electroporated with siRNA IFI16 or siRNA ctrl or left not
electroporated (NE) and then infected with the endotheliotropic
HCMV strain VR1814 at MOI of 0.1 or 1. As shown in Figure S2,
and in line with the results obtained using fibroblasts, replication of
the VR1814 strain was significantly increased at an MOI of 1
compared to that observed in cells treated with siRNA ctrl (,7
fold increase). In contrast to our previously observations in
fibroblasts, at the lower MOI the level of virus replication in
endothelial cells in the absence of IFI16 was still different but at
lower degree from that observed in controls. This difference may
be explained by the fact that the efficiency of infection and
replication of the VR1814 strain in endothelial cells is much lower
than that of the AD169 virus strain in fibroblasts [26]. Taken
together, these results demonstrate that IFI16 may also restrict
HCMV replication in physiologically relevant target cells in vivo
such as endothelial cells.
IFI16 overexpression impairs HCMV replication by
inhibiting early and late viral gene expression
To gain more insight into the antiviral activity of IFI16, we
focused on the HCMV model. HELFs were infected with AdV
IFI16 or AdV LacZ at an MOI of 200 and the IFI16 protein
content monitored by Western blot analysis. As shown in
Figure 3A, IFI16 protein levels started to increase as early as 24
hpi and continued to increase until 48 hpi. When HELFs
overexpressing wt IFI16 for 24 h were infected with HCMV at
an MOI of 0.1, a ,2.5 log decrease in viral production was
observed on day 4, compared to HELFs left untransduced or
transduced with the control AdV LacZ gene (Figure 3B, left
panel). A similar pattern was observed at the higher MOI of 1, but
with lower levels of virus growth suppression (,1 log reduction)
(Figure 3B, right panel). Thus, consistent with the previous
findings, which showed increased virus replication in the absence
of IFI16, the overexpression of IFI16 strongly inhibits HCMV
replication.
To investigate the molecular basis of the antiviral activity of
IFI16, we examined the effects of its overexpression on different
phases of the HCMV replication cycle. To this purpose, HELFs
were infected with AdV IFI16 or AdV LacZ (MOI of 200) or left
uninfected (mock), and infected 24 h later with HCMV (MOI of 1)
for a further 24 h. The amounts of IE (IE1 and IE2), UL44, UL54,
and UL83 transcripts were then assessed by quantitative real-time
PCR as markers of IE (IE1 and IE2), E (UL44 and UL54), and L
(UL83) mRNAs (Figure 4A). According to Cristea et al [23]
results, we saw no difference in expression of the products of
immediate early genes (IE1 and IE2) between IFI16-overexpress-
ing and LacZ- or mock-infected cells. In contrast, mRNA synthesis
of early (UL44 and UL54) and early-late (UL83) genes was
significantly reduced (2-, 6- and 6- fold respectively) in the cells
expressing IFI16. Total protein extracts were then analyzed for
their content of immediate early (IE), early (UL44), and early-late
(UL83) proteins by immunoblotting with specific antibodies. As
shown in Figure 4B, the expression of the HCMV UL44 and
UL83 proteins was strongly impaired in AdV IFI16-infected
HELFs compared to that seen in control cells, mirroring the results
obtained at the mRNA level. The expression of these proteins is
indispensable for productive HCMV infection (reviewed in [1]). A
possible explanation for these findings is that IFI16 may exert its
antiviral effect by inhibiting the synthesis or function of an
HCMV-encoded component critical for viral DNA synthesis and/
or maturation. Further support to this hypothesis comes from the
experiments in which viral DNA synthesis was measured in
HELFs transduced with IFI16 or LacZ genes for 24 h and then
infected with HCMV. As shown in Figure 4C, starting at 48 hpi
and continuing at later time points (72 and 96 hpi), a significant
decrease in the number of viral DNA copies was observed in
HELFs transduced with the IFI16 gene compared to cells left
untransduced or transduced with the LacZ gene.
Taken together, these results indicate that IFI16 reduces
HCMV replication by inhibiting the expression of E and L genes
required for the viral DNA synthesis and completion of the viral
productive cycle.
IFI16 overexpression inhibits the transcription of the
HCMV UL54 and UL44 gene in the context of viral
infection
Previous studies have shown that cotransfection of IFI16 and a
CAT reporter gene containing the wild type UL54 promoter
assays. The data shown are the average of three experiments 6 SD (*p,0.05, **p,0.01, ***p,0.001, one-way ANOVA followed by Bonferroni’s post
test). B) HELFs were transfected with siRNA IFI16 or siRNA ctrl or left not electroporated (NE) and IFI16 expression assayed by Western blotting on the
indicated days (d) with anti-IFI16 polyclonal Abs. b-actin was included as a loading control. C) HELFs were treated with siRNA as described for panel A
and then infected with HCMV at an MOI of 0.05 (left panel) or 1 (right panel) PFU/cell. Cell-free supernatants were harvested on the indicated hours post
infection and the virus amounts determined by plaque assays. The data shown are the average of three experiments 6 SD.
doi:10.1371/journal.ppat.1002498.g001
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suggesting an interplay between IFI16 and transcription factors
responsible for UL54 promoter activation. These observations
were made, however, in uninfected cells using the UL54 essential
promoter as a target of cellular transcription factors.
To investigate whether IFI16 overexpression may affect UL54
gene promoter activity in HCMV-infected cells, reporter plasmids
containing UL54 promoter segments containing progressive 59
deletions were transfected into HELFs left uninfected or
subsequently infected with AdV IFI16 or AdV LacZ as control.
Twenty-four hours later, the cells were infected with HCMV to
transactivate the UL54 promoter and luciferase activity assessed
following an additional 24 h. As shown in Figure 5A, HCMV
infection significantly increased luciferase activity of all the
reporter constructs when examined in mock- (data not shown)
or LacZ-overexpressing HELFs compared to HCMV-uninfected
Figure 2. Effect of dominant negative IFI16 (dnIFI16) overexpression on Herpesvirus growth. A) Western blot analysis was carried out to
detect IFI16 and V5 expression in HELFs stably transduced with the recombinant Lentivirus carrying the full-length IFI16 (wtIFI16), mutated forms of
IFI16 (dnIFI16), lacking the PYD domain (DPYDIFI16, indicated as DDIFI16), the HIN-B domain (DHIN-BIFI16, indicated as DBIFI16) or expressing the
LacZ transgene as negative control (LacZ). b-actin immunodetection was used to control for equal loading. B) HELFs carrying wtIFI16, DDIFI16,
DBIFI16 or the control LacZ gene were infected with HCMV at the indicated MOI. Viral supernatants were collected at 96 hours post infection (hpi)
and analyzed by standard plaque assay. The data shown are the average of three experiments 6 SD (*p,0.05, one-way ANOVA followed by
Bonferroni’s post test).
doi:10.1371/journal.ppat.1002498.g002
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infection, luciferase activity decreased by more than 75% or 90%
in cells transfected with the pUL54 0.4 or pUL54 0.3 indicator
plasmids respectively, compared to AdV LacZ control cells.
Similarly reduced levels (70%) were also observed with the
minimal promoter construct pUL54 0.15 that contains nucleotide
sequences up to 2150 relative to the transcription start site,
including the DR-ATF and IR-1 responsive elements. Together,
these results indicate that inhibition of HCMV replication by
IFI16 is consequent to DNA polymerase activity downregulation.
The HCMV DNA polymerase promoter contains a DNA
element located between 254 and 243 relative to the transcrip-
tion start site that has been shown to be required for both basal
transcriptional activity and transactivation by IE2 [28,29].
Mutations of the 8-bp inverted repeat element 1 (IR-1) diminishes
transactivation by IE2 and abrogates the binding of cellular
transcription factors, such as Sp1 [30,31]. To investigate the
involvement of IR-1 in IFI16-mediated UL54 suppression,
transient transfection assays were performed using luciferase
reporter constructs driven by versions of the minimal UL54
promoter (pUL54 0.15) mutated in either the DR-ATF or IR-1
element. Mutations in the DR-ATF element of the UL54
promoter (positions -82- 95) (pUL54 0.15 mut DR-ATF) slightly
affected transactivation of the promoter by HCMV (141660 RLU
vs. 88331 RLU) but did not impact on IFI16-mediated
suppression (42930 RLU vs 34180 RLU), suggesting that the
Figure 3. Overexpression of IFI16 reduces HCMV replication by inhibiting viral early and late gene expression. A) Kinetics of
Adenovirus-mediated IFI16 overexpression. HELFs were infected with AdV IFI16, AdV LacZ (MOI of 200 PFU/cell), or mock-infected. At the indicated
hours post infection (h), total cell extracts were prepared and subjected to Western blot analysis using anti-IFI16 polyclonal Ab. b-actin served as the
internal control. B) HELFs were infected with AdV IFI16, AdV LacZ (MOI of 200 PFU/cell), or left untreated. After 24 hours, cells were infected with
HCMV at an MOI of 0.1 (left panel) or 1 (right panel) PFU/cell. Cell-free supernatants were harvested on the indicated days post infection and the
amounts of HCMV were determined by standard plaque assay. The data shown are the average of three experiments 6 SD.
doi:10.1371/journal.ppat.1002498.g003
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PLoS Pathogens | www.plospathogens.org 6 January 2012 | Volume 8 | Issue 1 | e1002498Figure 4. IFI16 impairs early and late, but not immediate early gene expression. A) HELFs were infected with AdV IFI16, AdV LacZ (MOI of
200 PFU/cell), or left untreated. After 24 hours, cells were infected with HCMV at an MOI of 1 PFU/cell. Total RNA was isolated at 24 hours post
infection and assayed by quantitative real-time PCR to determine the relative levels of viral transcripts. Levels of viral mRNA are presented normalized
to the levels of cellular b-actin. The data shown are the average of three experiments 6 SD (*p,0.05, **p,0.01, one-way ANOVA followed by
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accordance with the results previously reported by Luu et al. [30]
and Wu et al. [31], the IR-1 mutation in the construct pUL54 0.15
(pUL54 0.15 IR-1 mut) caused more than a 95% decrease in
HCMV-induced UL54 promoter activity compared to the wild
type pUL54 0.15, consistent with its prominent role in the control
of UL54 promoter transactivation by HCMV. IFI16 overexpres-
sion before HCMV infection did not further reduce the HCMV-
driven transactivation of the IR-1 mutant construct in terms of
luciferase activity, indicating that the DNA target of IFI16
suppressor activity might reside in the IR-1 element.
Suppression of UL54 promoter transactivation by IFI16 is
apparently at variance with the findings of Cristea et al. [23] who
showed that HCMV pUL83 stimulates activity of the major
immediate-early promoter (MIEP) through its interaction with
cellular IFI16 protein. Therefore, it would seem possible that
positive or negative modulation of promoter activity by IFI16
might depend on the type of promoter itself and the specific
transcription factors interacting. To investigate this hypothesis, the
pUL54 0.15 construct and the pMIEP-Gl3 plasmid, a reporter
plasmid in which the luciferase gene is driven by the HCMV
major immediate-early promoter (MIEP), were transfected into
HELFs that were then infected with either AdV IFI16 or AdV
LacZ followed by HCMV infection. As expected, luciferase
expression driven by the pUL54 0.15 promoter was inhibited
(Figure 5B). In contrast, IFI16 overexpression significantly
increased MIEP activity, confirming that modulation of transcrip-
tion by IFI16 is highly specific and largely dependent on the type
of target promoter (e.g. UL54 promoter vs. the MIEP).
To investigate whether the IFI16/Sp1 interaction affects the
expression of other viral genes, the expression of UL44, a
component of the HCMV DNA polymerase complex, was also
investigated. UL44 protein expression was affected by IFI16
overexpression (Figure 4B), thus strengthening the evidence
indicating an antiviral role of IFI16. Transfection experiments
were performed using constructs containing the luciferase gene
driven by the UL44 promoter containing progressive deletions in
its DNA element responsive to different transcription factors [32–
34]. Consistent with the results obtained with the UL54 promoter,
IFI16 overexpression significantly reduced luciferase activity by
more than 70% in cells transfected with the pUL44-600-3T
plasmid (containing the UL44 promoter from 2613 nt to +67
relative to the proximal transcription start site and all three TATA
elements) or the pUL44-600-1T indicator plasmid (containing the
UL44 promoter from 2613 nt to 292 relative to the proximal
transcription start site and only the distal TATA element),
compared to AdV LacZ control cells. Interestingly, in the absence
of the Sp1 responsive element upstream of the three transcription
starting sites (from 2613 nt to 2164 relative to the proximal
transcription start site), IFI16 stimulated the activity of the pUL44-
160-3T indicator plasmid, as seen with the MIEP promoter. These
results suggest that the IFI16/Sp1 interaction is important for
modulating the activity of target viral genes.
Previous mutagenesis scanning and EMSA analyses of the
UL54 254/243 sequence (IR-1 element) indicated that Sp1 is the
cellular factor responsible for abetting the action of HCMV IE
proteins at the UL54 promoter [30]. To investigate whether Sp1
could be the target of IFI16, causing the modulation of IR-1
activity in the context of HCMV infection, nuclear extracts from
AdV IFI16- or AdV LacZ-transduced HELFs infected at an MOI
of 200 for 24 h and then with HCMV at an MOI of 2 for 24 h
were analyzed by EMSA using an IR-1 oligonucleotide probe.
Consistent with the results of Luu and Flores [30], the
oligonucleotide spanning the IR-1 element formed two major
complexes (1 and 2) with nuclear extracts from cells infected with
HCMV 24 h earlier (Figure 6A, lane 2) that were reduced in the
mock-infected cells (lane 1). These complexes could be specifically
competed by a 100-fold excess of unlabeled IR-1wt (lane 3), but
not by the same concentration of a mutated oligonucleotide (lane
4). In HELFs overexpressing IFI16 (lane 5), subsequently infected
with HCMV (lane 6), and incubated with the labeled IR-1wt
oligonucleotide, the generation of both complex 1 and 2 was
significantly reduced at 24 hpi, suggesting that IFI16 inhibits the
binding of both cellular and viral-induced transcription factors to
the IR-1 sequence. The suppression of complex 1 and 2 must be
due to IFI16 since infection of HELFs with AdV LacZ (used as
control) does not impair the induction of the two complexes by
HCMV (lanes 7 and 8). To confirm that the complexes 1 and 2
impaired by IFI16 overexpression contained Sp1, antibodies
specific for Sp1 protein or unrelated antibodies (ctrl) were added to
EMSA reactions for supershift analysis. As shown in Figure 6B,
addition of anti-Sp1 (lanes 3 and 4), but not unrelated antibodies
(lanes 5 and 6), supershifted the protein complexes of both mock
and HCMV-infected cells, indicating that Sp1 is a component in
both IFI16-suppressed complexes 1 and 2. In line with the results
reported by Luu and Flores [30], anti-IFI16 antibodies did not
alter the mobility of the two complexes, demonstrating that IFI16
does not form part of either protein complex 1 or 2 (data not
shown). Altogether, these results demonstrate that suppression of
UL54 promoter activity by IFI16 is associated with inhibition of
the formation of Sp1-containing complexes with the IR-1 element.
Transactivation of the UL54 promoter by HCMV is
inhibited upon IFI16 binding to Sp1
To identify the mechanisms underlying the suppression of Sp1-
induced transcription of the UL54 promoter by IFI16, immuno-
precipitation (IP) experiments and in vivo chromatin IP (ChIP)
assays were performed. IP was carried out on infected and
uninfected cell lysates using polyclonal Abs recognizing IFI16 or a
control antibodies (ctrl). Immunoprecipitated proteins were
examined by Western blotting using antibodies recognizing Sp1
(Figure 7A). A species of the same size as Sp1 that reacted with the
polyclonal anti-Sp1 antibody could be observed in the nuclear
protein extracts (Figure 7A, lanes 1, 2, 3) or and in the proteins
immunoprecipitated from the infected lysates using the anti-IFI16
Abs (Figure 7A, lanes 8, 9). It is also worth noting that a band of
greater intensity was observed in lysates derived from HCMV-
infected cells overexpressing IFI16 (Fig. 7A, lane 9). In the
uninfected cell lysates (mock), no migrating band of the same size
as Sp1 could be detected (Figure 7A, lane 7). Similarly, no bands
were detected when infected cell lysates were immunoprecipitated
with control antibodies (ctrl) and reacted with anti-Sp1 antibodies
(Figure 7A, lanes 4–6). Finally, the presence of IFI16 protein was
also confirmed in the very same nuclear cell extracts (Fig. 7A,
Bonferroni’s post test). B) Cells were infected as described in the legend for panel A. Thirty mg of protein were analyzed by Western blotting for viral
protein expression at 48 hours post infection and b-actin was used as internal control. C) Cells were infected as described in the legend for panel A.
Viral DNA was isolated at the indicated hours post infection (hpi) and analyzed by quantitative real-time PCR, whereby primers amplified a segment
of the E1 gene to determine the number of viral DNA genomes per nanogram of cellular reference DNA (18S rRNA gene). The data shown are the
average of three experiments 6 SD (*p,0.05, **p,0.01, ***p,0.001, one-way ANOVA followed by Bonferroni’s post test).
doi:10.1371/journal.ppat.1002498.g004
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PLoS Pathogens | www.plospathogens.org 8 January 2012 | Volume 8 | Issue 1 | e1002498Figure 5. Effects of IFI16 overexpression on the activity of HCMV UL54, UL44, and MIEP promoters. A) Luciferase reporter plasmids
containing HCMV UL54 promoter segments progressively deleted from the 59 end and mutated in the IR-1 or DR-ATF elements were transfected into
HELFs that were subsequently infected with either AdV LacZ or AdV IFI16 at an MOI of 200. 24 hours later, cells were infected with HCMV (MOI of 0.5)
and luciferase activity assessed after a further 24 hpi. B) Luciferase reporter plasmids containing the MIEP (major immediate-early promoter) segment
were transfected into HELFs subsequently infected as described for panel A. C) Luciferase reporter plasmids containing HCMV UL44 promoter
segments progressively deleted from the 59 end and the 39 end were transfected into HELFs subsequently infected as described for panel A. Sp1,
putative binding sites for Sp1 transcription factor; oval circles indicates TATA boxes. Experiments were repeated at least three times and one
representative result is shown (mean 6 SD) (*p,0.05, **p,0.01, ***p,0.001, unpaired t test for comparison of AdV LacZ vs AdV IFI16).
doi:10.1371/journal.ppat.1002498.g005
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overexpressing and HCMV infected HELFs, IFI16 and Sp1
physically interact. It has been demonstrated elsewhere that IFI16
binds to DNA [35]. DNA-binding proteins can associate during IP
due to their adjacent binding on DNA rather that due to protein-
protein interactions [36]. To determine whether nucleic acid is
required for the IFI16/Sp1 association, IP was performed using an
anti-IFI16 Ab or a control Ab (ctrl) in the presence or absence of
benzonase (a non specific nuclease), and the IPs were probed by
Western blot using anti-Sp1 Ab. No Sp1 was detected in IPs using
the control Ab (Figure 7B, lanes 2 and 3). In contrast, Sp1 was
detected in IPs from infected lysates in both the absence (lane 4)
and presence (lane 5) of benzonase. To confirm the action of
benzonase on nucleic acid, the cell lysates analyzed in Figure 7B
were examined on an ethidium bromide-stained agarose gel. In
the absence of benzonase, a robust staining of nucleic acid could
be seen, whereas staining in the presence of benzonase was no
more intense than that of a no-sample control (data not shown).
Figure 6. IFI16 impairs IR-1 binding. A) Nuclear protein extracts from HELFs infected with AdV IFI16 or AdV LacZ at an MOI of 200 for 24 hours
and then with HCMV at an MOI of 2 for 24 hours were incubated with a radiolabeled oligonucleotide containing the consensus IR-1 binding site.
Competition experiments were performed with 100-fold excess of cold specific oligonucleotide in either the wild type or the mutated form. B) Super-
shift experiments were performed by adding polyclonal antibodies against Sp1, control antobody (ctrl). Experiments were repeated at least three
times and one representative result is shown.
doi:10.1371/journal.ppat.1002498.g006
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PLoS Pathogens | www.plospathogens.org 11 January 2012 | Volume 8 | Issue 1 | e1002498Altogether, these results demonstrate that suppression of UL54
transcription by IFI16 is accompanied by the displacement of Sp1
from its promoter due to its direct association with IFI16.
To corroborate these results further, the binding of Sp1 to the
UL54 promoter in the presence of IFI16 was then analyzed in vivo
by ChIP assay. Formaldehyde cross-linked sonicated chromatin
fragments from HELFs infected with AdV IFI16 or AdV LacZ
24 h earlier and then infected with HCMV for 24 h were
immunoprecipitated using an anti-Sp1 polyclonal antibody. The
DNA released from the immunocomplexes was then analyzed by
quantitative real-time PCR to detect the enrichment of the IR-1
sequence of the UL54 promoter in the immunoprecipitates. The
rate of amplification was verified using cross-linked non-immuno-
precipitated chromatin (input). Consistent with the EMSA and IP
results, real-time PCR analysis of the purified ChIPed DNA
showed that the Sp1 antibody pulled approximately 80% more
Sp1-bound UL54 promoter DNA down in extracts from AdV
LacZ-infected HELFs compared with those from AdV IFI16-
infected HELFs (Figure 7C). Unrelated, affinity-purified polyclon-
al antibodies, used as negative control, did not immunoprecipitate
the complex containing the UL54 promoter (data not shown).
Altogether, these findings indicate that the suppression of UL54
gene transcription in the presence of IFI16 is due to the inhibition
of Sp1 recruitment to its promoter.
To learn more about the basis of the IFI16/Sp1 interaction and
its effects on HCMV replication, cell lines stably expressing the
V5-tagged mutant forms of IFI16, namely DDIFI16, DBIFI16, or
the full-length IFI16 (wtIFI16), were infected with HCMV at an
MOI of 2 PFU/cell. Twenty-four hours later, IP was carried out
using monoclonal Ab recognizing the V5 tag, or control antibody
(ctrl). Immunoprecipitated proteins were examined by Western
blotting using antibodies recognizing Sp1. As shown in Figure 7D,
a species of the same size as Sp1 could be observed in the total
nuclear extracts (Figure 7D, top panel, lane 1–3). A band
migrating at a similar molecular weight could also be observed
in the proteins immunoprecipitated from HELFs overexpressing
the full length IFI16 form (wtIFI16) (Figure 7D, lane 9). In
contrast, no bands corresponding to Sp1 could be observed in the
immunoprecipitates from the DBIFI16 cell line when blotted with
anti-Sp1 antibodies (Figure 7D, lane 8). A detectable, although
weaker band corresponding to Sp1 could be observed in the
immunoprecipitates from the DDIFI16 cell line (Fig. 7D, lane 7).
As expected, protein extracts immunoprecipitated from infected
cell lines with control antibodies (ctrl) did not display any
migrating band (Figure 7D, lane 4–6). Finally, the presence of
V5-tagged proteins was also confirmed in the very same nuclear
cell extracts (Fig. 7D, bottom panel). Altogether, these results
demonstrate that the interaction of IFI16 with Sp1 most likely
depends on the integrity of the HIN domains present on the full
length protein. In support of this hypothesis, the DDIFI16 mutant
containing the two HIN domains partially maintained its ability to
bind Sp1, although at levels much lower than those of the wtIFI16.
By contrast, the DBIFI16 mutant lacking the HIN-B domain
completely lost its ability to interact with Sp1.
Suppression of HCMV replication by IFI16 does not
require IFN-b antiviral activity
IFI16 was recently identified to be an intracellular sensor of
HSV-1 DNA, which stimulates the expression of IFN-b and pro-
inflammatory genes through activation of IRF3 and NF-kB
transcription factors [8]. To clarify whether IFI16 could suppress
HCMV replication through IFN-b induction, HELFs were
electroporated with siRNA specific for IFN-b or siRNA ctrl or
left not electroporated (NE), infected with AdV IFI16 at an MOI
of 200, and 24 h later with HCMV at an MOI of 0.1. At different
time points post infection, HCMV yield was measured. As shown
in Figure 8A, this treatment led to the inhibition of IFN-b
induction in response to HCMV infection. By contrast, suppres-
sion of IFN-b production did not prevent the inhibition of HCMV
replication by IFI16 overexpression, demonstrating that IFI16
does not require functional IFN-b and that it directly inhibits
HCMV replication (Figure 8B). IFN-b production was wiped out
by siRNA specific for IFN-b, as proven by the finding that an
inducer of IFN-b (poly I:C) failed to block HCMV replication
upon HELF treatment with siRNA IFN-b, while it was blocked in
cells treated with siRNA ctrl (data not shown).
Discussion
This study demonstrates that IFI16 acts as restriction factor for
HCMV replication. Inhibition of HCMV growth was observed by
adopting two different experimental approaches. In the first
approach, primary HELFs were generated whereby the IFI16
protein underwent a long-lasting knockdown through the use of
either siRNAs or the overexpression of dominant negative forms of
the IFI16 protein that lacked the death domain (PYD) at the N-
terminus or the HIN-B domain at the C-terminus. HELFs were
chosen for two main reasons: i) they are fully permissive to
HCMV; and ii) they are characterized by a very low basal level of
IFI16 expression that can be adequately up-regulated following
transduction with the AdV IFI16 vector. When HCMV
replication was analyzed in these cells, in either the absence of
IFI16 or in the presence of an inactivated form of IFI16, viral yield
at low MOI was significantly increased. The finding that IFI16
counteracts HCMV replication is further supported by the
outcome of the experiments using HELFs overexpressing IFI16.
In these cell cultures, the HCMV yield at low MOI was severely
impaired, confirming that IFI16 is indeed endowed with antiviral
Figure 7. Interplay between Sp1 and IFI16 down-regulates HCMV replication. A) Nuclear cell protein extracts from HELFs mock infected
(lanes 1, 4, 7), infected with HCMV at an MOI of 2 for 24 hours (lanes 2, 5, 8), or infected with AdV IFI16 or AdV LacZ (data not shown) at an MOI of 200
for 24 hours and then with HCMV (lanes 3, 6, 9) were immunoprecipitated with polyclonal antibodies against IFI16 or control antibody (ctrl). Samples
were then immunoblotted with polyclonal antibodies against Sp1 or IFI16. B) Infected cell lysates were immunoprecipitated with anti-IFI16 polyclonal
antibodies in the absence (lane 2 or 4) or presence of benzonase (lanes 3 and 5) or with control antibody (ctrl). Proteins from the IP were analyzed by
Western blotting using polyclonal antibody recognizing Sp1. C) Nuclear extracts from HELFs mock infected or infected with AdV IFI16 or AdV LacZ at
an MOI of 200 for 24 hours and then with HCMV at an MOI of 2 for 24 hours were analyzed by ChIP assay using anti-Sp1 rabbit polyclonal antibody.
Sp1-coprecipitating DNA was analyzed by quantitative real-time PCR with IR-1 sequence specific primers. An unrelated rabbit polyclonal anti-serum
was used as control (data not shown). Non-immunoprecipitated whole cell extract (input) obtained from AdV LacZ- or AdV IFI16-infected cells was
employed to normalize the IR-1 viral DNA subjected to immunoprecipitation. Experiments were repeated at least three times and one representative
result is shown (mean 6 SD) (***p,0.001, unpaired t test). D) Nuclear cell protein extracts from HELFs stably transduced with the recombinant
Lentivirus carrying the full-length IFI16 protein (IFI16wt), or dnIFI16 ORFs (DDIFI16 or DBIFI16), were infected with HCMV at an MOI of 2 for 24 hours,
immunoprecipitated with monoclonal antibodies against flag V5 or control antibodies (ctrl), and immunoblotted with polyclonal antibodies against
Sp1 (top panel) or flag V5 (bottom panel).
doi:10.1371/journal.ppat.1002498.g007
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protein level showed that IFI16 did not affect IE expression, but
rather a viral replication step down-stream of IE expression. In
line with this finding, and by measuring the DNA viral load, we
demonstrated that IFI16 down-regulates viral DNA synthesis by
affecting the bona fide activity of the UL54 DNA polymerase gene
and the UL44 gene. Definitive support for this came from
transfection experiments which showed IFI16 overexpression to
Figure 8. Suppression of HCMV replication by IFI16 does not require IFN-b antiviral activity. HELFs were electroporated with a mixture of
four different small interfering RNA (siRNA IFN-b) or scrambled control siRNA (siRNA ctrl), or left not electroporated (NE), and then infected with AdV
IFI16 or AdV LacZ (MOI of 200 PFU/cell) before subsequent infection with HCMV 24 hours later (MOI of 0.1 PFU/cell). A) Total RNA was isolated
24 hours post HCMV infection and IFN-b mRNA expression was determined by quantitative real-time PCR. Levels of IFN-b mRNA are presented
normalized to the levels of cellular b-actin. Experiments were repeated at least three times and one representative result is shown (mean 6 SD). B)
Cell-free supernatants were harvested at the indicated hours post infection (hpi) and virus amounts determined by plaque assay. The data shown are
the average of three experiments 6 SD (*p,0.05, **p,0.01, one-way ANOVA followed by Bonferroni’s post test).
doi:10.1371/journal.ppat.1002498.g008
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promoters, responsible for viral DNA synthesis. Previous studies
have indeed shown that IFI16 can be purified by DNA affinity
chromatography using a region of the UL54 [30]. Moreover,
cotransfection of IFI16 and a CAT reporter gene containing the
wild type UL54 promoter results in a dose-dependent decrease in
reporter activity [27], suggesting an interplay between IFI16 and
transcription factors responsible for UL54 promoter activation. All
these observations were made, however, in uninfected cells using
the UL54 essential promoter as a simple target of cellular
transcription factors and the mechanisms responsible for the
inhibition of UL54 transactivation by IFI16 in infected cells
remained to be elucidated. Therefore, to provide new evidence
about the action of IFI16 in the context of HCMV infection,
promoter scan analyses, EMSA and ChIP, were each performed in
IFI16-overexpressing HELFs infected with HCMV. The results
obtained demonstrate that in order to exert its antiviral activity
IFI16 binds and displaces the Sp1 transcription factor interacting
with the responsive IR-1 element present in the UL54 promoter.
Sp1 detachment from its DNA cognate element leads to a decrease
in HCMV DNA synthesis and, as a consequence, the inhibition of
virus replication. Consistent with this, we have previously
demonstrated that activation of the NF-kB response is mediated
by an IFI16-induced blockade of Sp1-like factor recruitment to the
promoter of the IkBa gene, which encodes the main NF-kB
inhibitor [37].
In order to provide new insights into the mechanisms of the
interaction of IFI16 with Sp1 and its effects on HCMV replication,
we produced cell lines overexpressing mutated forms of IFI16
lacking the HIN-B domain (DBIFI16) or the PYD domain
(DDIFI16). Virus yield experiments demonstrated that HCMV
replication in the DDIFI16 cell line was enhanced compared to
that in the cell lines expressing the wild type IFI16 or IFI16 lacking
the HIN-B domain (DBIFI16). A conceivable explanation for these
results could be the following. The mutated form of IFI16 lacking
the HIN-B domain (DBIFI16) is unable to physically interact with
Sp1 and therefore can no longer relieve the suppressive activity of
endogenous IFI16 on viral promoters, such as UL54 and UL44. In
contrast, in cells lacking the PYD domain (DDIFI16), IFI16 to
some extent maintains its capability to interact with Sp1 and
compete with the endogenous form on the viral promoter. As a
consequence, the suppressive activity of the endogenous IFI16
protein is retained, stimulating HCMV replication. The finding
that the HIN-B domain is responsible for the Sp1 interaction is in
line with results recently reported by Liao et al. [38], which show
that the HIN-B and HIN-A domains are together responsible for
the IFI16/p53 interaction. These results corroborate the notion
that IFI16 is a modular protein and that its different functions
correspond to its different domains.
A different role of IFI16 in HCMV replication has been
demonstrated by Cristea et al. [23], who identified the interaction
of pUL83 (pp65) with IFI16 throughout the course of HCMV
infection and showed that pUL83 recruits IFI16 to the major
immediate-early promoter (MIEP) and stimulates, rather than
inhibiting, MIEP activity. Consistent with these observations,
when we compared UL54 promoter activity with MIEP activity in
IFI16 overexpressing cells, stimulation of only the latter promoter
was observed. The differential sensitivity of the two promoters to
IFI16 activity may be explained by the presence of four NF-kB
responsive elements on the MIEP. Functional analysis of the
ICAM-1 promoter by deletion- or site-specific mutagenesis has
indeed demonstrated that NF-kB is the main mediator of IFI16-
driven gene induction [37]. NF-kB activation appears to be
triggered by IFI16 through a novel mechanism involving
suppression of IkBa mRNA and protein expression. Furthermore,
to study the activity of IFI16 in p53-mediated gene expression,
Fujiuchi et al. [39] examined BAX promoter (a p53 target gene)
activation by coexpressing p53 and IFI16. When the proteins were
coexpressed, promoter activity was enhanced up to 17-fold.
Consistent with the results showing the collaboration of p53 and
IFI16 in transcription, endogenous levels of BAX, p21WAF1, and
HDM2 were synergistically induced by expressing both proteins,
as shown by Western blot analysis. Taken together, these results
demonstrate that depending on the factors and the type of
promoter it is interacting with, IFI16 may act either as a positive
or negative transcription regulatory factor. Moreover, we have
previously observed that murine CMV (MCMV) replication was
delayed in mouse embryo fibroblasts (MEF) following inactivation
of the IFI16 mouse homolog Ifi204 with a p204-dominant-
negative mutant. These results suggested that the activity of this
protein was required for efficient MCMV replication [24]. These
discrepancies may be thus explained by the findings that IFI16
requirement varies during HCMV replication and depends on the
MOI employed.
IFI16 has been shown to act as an innate immune sensor of
intracellular dsDNA [35]. Upon sensing dsDNA, the IFI16 protein
triggers the induction of IFN-b. IFI16 directly associated with
IFN-b-inducing viral DNA motifs recruits STING a critical
mediator of the IFN-b response to DNA. It is therefore possible
that IFI16 inhibits HCMV replication through the induction of
IFN-b. This is quite unlikely, however, in the light of the following
observations. First of all, the outcome of the transfection
experiments and EMSA indicates that IFI16 directly interacts
with and down-regulates Sp1, which is responsible for UL54
promoter activation. Secondly, knockdown of the IFN-b gene by
specific siRNAs does not impair the ability of IFI16 to down-
regulate HCMV replication. Finally, the addition of anti-IFN-type
I antibodies does not impair the capability of IFI16 to suppress
HCMV replication (unpublished). Thus, IFI16 appears to directly
inhibit virus HCMV replication rather than down-regulating viral
growth through activation of an IFN pathway.
Overall, although the detailed mechanisms of IFI16-mediated
repression of viral E and L gene expression remain to be fully
determined, the results presented in this study congruently
demonstrate that the actions of IFI16 contribute to a cell’s
intrinsic repression mechanism of HCMV gene expression. It
remains to be determined, however, how the virus counteracts
IFI16 activity and shifts the balance toward viral evasion and its
consequent growth.
Materials and Methods
Cells and viruses
Low-passage human embryonic lung fibroblasts (HELFs),
human embryo kidney 293 cells (HEK 293) (Microbix Biosystems
Inc.), African green monkey kidney cells (Vero) and mouse
connective tissue fibroblasts (L929) were grown in Eagle’s minimal
essential medium (Gibco-BRL) supplemented with 10% fetal
bovine serum (FBS; Gibco-BRL). Human umbilical vein endo-
thelial cells (HUVECs) were isolated by trypsin treatment of
umbilical cord veins cultured in Endothelial Growth Medium
(EGM) corresponding to Endothelial Basal Medium (EBM)
(Clonetics, San Diego, CA) containing 2% FCS, human
recombinant vascular endothelial growth factor (hrVEGF), basic
fibroblast growth factor (bFGF), human epidermal growth factor
(hEGF), insulin growth factor (IGF-1), hydrocortisone, ascorbic
acid, heparin, gentamycin and amphotericin B (1 mg/ml each).
Experiments were carried out with cells at passages 4–8. HCMV
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were propagated on HELF cells, clinical isolates of HSV-1 and
HSV-2 on Vero cells and Vesicular Stomatitis Virus (VSV)
serotype Indiana on L929 cells and titrated by standard plaque
assay, as previously described [40]. HCMV VR1814 is a
derivative of a clinical isolate and grows efficiently on HUVECs
[41].
Inhibition of IFI16 and IFN-b expression
HELF cells were transiently transfected with a MicroPorator
(Digital Bio) according to the manufacturer’s instructions (1200 V,
30 ms pulse width, one impulse) with a pool of IFI16 small
interfering RNAs (siRNA IFI16), siRNA IFN-b, or control siRNA
(siRNA ctrl) as negative control (final concentration: 300 nM;
Qiagen). The IFI16 and IFN-b siRNA sequences are reported in
Table S1. IFI16 or IFN-b siRNA-induced blockade was checked
by immunoblotting with rabbit anti-IFI16 antibodies or by real-
time PCR with IFN-b specific primers (Table S1) respectively, at
the time points indicated.
Recombinant lentiviral and adenoviral vectors
Lentiviral vectors carrying the full-length IFI16 ORF (wt IFI16)
or IFI16 ORF lacking the PYD domain (DPYDIFI16) or the HIN-
B domain (DHIN-BIFI16) or the LacZ gene as a control, were
generated as described by Azzimonti et al. [42]. To obtain
lentiviral lines, HELFs were transduced with the recombinant
Lentivirus and successfully transduced cells selected using
blasticidin (4 mg/ml; for a maximum of 10 days). Transduction
efficiency was assessed by immunoblotting for the V5-epitope. The
adenovirus transfer vector pAC-CMV IFI16 was constructed as
described in Gugliesi et al. [43].
Plasmids
The HCMV UL54 (pol) promoter sequences (positions 2425 to
+15 relative to the UL54 transcription start site, GenBank
NC_006273) were amplified by PCR using purified HCMV
AD169 DNA as the template and the primer sets reported in
Table S1. The 59- and 39-primers were engineered with HindIII
and KpnI restriction sites. The PCR fragments were subsequently
digested and directionally cloned into the corresponding sites of
the pGL3-basic vector (Promega) to obtain the pUL54 0.4
construct. The pUL54 0.3 and pUL54 0.15 constructs were
derived from the pUL54 0.4 construct and contain UL54
promoter sequences 2285 to +15 and 2150 to +15, respectively.
These constructs were generated by PCR using the UL54
appropriate primers (Table S1). The fragments were then ligated
into the HindIII and KpnI sites of the pGL3-basic vector. To
obtain UL54-0.15 promoter sequence with inactivated IR-1 and
DR-ATF binding sites, the sequences of these sites were modified
by site-directed mutagenesis (Quick Change XL Site-Direct
Mutagenesis Kit, Stratagene). The IR-1 (254 to 242) and DR-
ATF (297 to 279) recognition sites of pUL54 0.15 were changed
into unique restriction sites (241 to 247, XbaI, and 289 to 295,
EcoRI, respectively) using the IR-1 mutant and DR-ATF mutant
oligonucleotides (Table S1) and their complementary oligonucle-
otides. The HCMV IE promoter-enhancer sequence (position
2666 to +19 relative to the IE1/IE2 transcription start site,
GenBank K03104.1) was amplified out of the purified HCMV
AD169 genome by PCR using the primer sets shown in Table S1.
The 59- and 39-primers were engineered using NheI and HindIII
restriction sites (underlined). The PCR fragments were subse-
quently digested and directionally cloned into the corresponding
sites of the pGL3-basic vector (Promega) to obtain the pMIEP
construct. The correctness of all the amplified viral sequences was
confirmed by sequencing. The HCMV UL44 promoter sequences
(positions 2613 to +67 relative to the proximal UL44 transcription
start site, GenBank NC_006273) were amplified by PCR using
purified HCMV AD169 DNA as the template and the primer sets
reported in Table S1. The 59- and 39-primers were engineered
with HindIII and BglII restriction sites. The PCR fragments were
subsequently digested and directionally cloned into the corre-
sponding sites of the pGL3-basic vector (Promega) to obtain the
pUL44-600-3T construct. The pUL44-660-1T and pUL44-160-
3T constructs were derived from the pUL44-600-3T construct and
contain the UL44 promoter sequences 2613 to 292 and 2164 to
+67 relative to the proximal UL44 transcription start site,
respectively. These constructs were generated by PCR using the
UL44 appropriate primers (Table S1). The fragments were then
ligated into the HindIII and BglII sites of the pGL3-basic vector.
The correctness of all the amplified viral sequences was confirmed
by sequencing.
Transfections and luciferase assay
Cells were electroporated using a Micro-Porator MP-100
(Digital BioTechnology), according to the manufacturer’s instruc-
tions (a single 1400 V pulse, 20 ms pulse width). After 24 h, cells
were infected with AdV IFI16 or the control indicator plasmid
AdV LacZ (MOI of 200 PFU/ml) and 24 h later the cells were
infected with HCMV AD169 (MOI of 0.5). Following a further
24 h, luciferase activity was measured using the Dual Luciferase
Reporter Assay System Kit (Promega) on a Lumino luminometer
(Stratec Biomedical Systems, Birkenfeld, Germany), as previously
described by Baggetta et al. [44].
Immunoblotting
Whole-cell protein extracts were prepared and subjected to
immunoblot analysis as described in Gugliesi et al.[43]. The
following antibodies were used: rabbit polyclonal anti- C-terminal
IFI16 antibodies (diluted 1:1000) or mouse monoclonal antibodies
(MAb) anti- IEA (IE1 plus IE2, 11-003; Argene, diluted 1:250),
UL44 (P1202-2, Virusys, clone CH16, diluted 1:500), UL83
(CA003-100, Virusys, clone 3A12, diluted 1:1000), V5 (R960-25,
Invitrogen, diluted 1:5000); MAb against b-actin (MAB1501R;
Chemicon, Temecula, CA, diluted 1:2000) were used as a control
for protein loading. Immunocomplexes were detected with sheep
anti-mouse or donkey anti-rabbit immunoglobulin antibodies
conjugated to horseradish peroxidase (Amersham) and visualized
by enhanced chemiluminescence (Super Signal; Pierce).
Nuclear extract isolation and electrophoretic mobility
shift assay (EMSA)
HELFs were infected with AdV IFI16 or control plasmid AdV
LacZ (MOI of 200 PFU/cell) for 24 h and subsequently infected
with HCMV strain AD169 (MOI of 2 PFU/cell) for 24 h. Nuclear
extracts were collected using the Nuclear Extract Kit (Active
Motif) according to the manufacturer’s instructions. Electropho-
retic mobility shift assays were carried out as previously described
[37]. Briefly, nuclear extracts (15 mg of protein) were incubated in
a binding buffer (10 mM Tris-HCl [pH 7.5], 50 mM NaCl,
0.5 mM EDTA, 0.5 mM dithiothreitol, 1 mM MgCl2, 5%
glycerol) containing 2 mg of poly (dI-dC) (GE Healthcare) and
the
32P oligonucleotide probe representing the wild-type (wt) or
mutated (mut) HCMV UL54 promoter IR-1 motif (2 65 to 235
respect to the transcription start site). Sequences are reported in
Table S1. For supershift experiments, 2 mg of polyclonal antibody
recognizing Sp1 (Millipore) or 2 mg of rabbit polyclonal anti-
human C-terminal IFI16 antibodies were used. Unlabeled 30-bp
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100-fold molar excess above the level of the probe.
Immunoprecipitation
For immunoprecipitation experiments, nuclear cell proteins
were obtained as described for EMSA analysis. 30 mg of proteins
were incubated with antibodies of interest (2 mg) for 1 h at room
temperature with rotation. The immune complexes were collected
using protein G–Sepharose beads (Sigma-Aldrich) for an addi-
tional 1 h at room temperature with rotation. The Sepharose
beads were pelleted and washed three times with RIPA buffer.
Finally, the proteins were eluted using Laemmli sample buffer and
resolved on 8% SDS-PAGE gel to assess the protein binding by
Western blotting. Where indicated, 400 U benzonase (Novagen)
was added for 30 minutes at 4uC after clarification of the lysate by
centrifugation, as described in Strang et al. [45].
Chromatin Immunoprecipitation (ChIP) assay
The ChIP assay was performed as previously described [37].
Briefly, HELFs were infected with AdV IFI16 at an MOI of 200
for 24 h and then with HCMV at an MOI of 2 for 24h. DNA-
protein complexes were cross-linked with PBS containing 1%
formaldehyde for 10 min, and the reaction was stopped via the
addition of glycine to a final concentration of 125 mM for 5 min
at room temperature. Nuclear extracts were collected by using the
nuclear Nuclear Extract Kit (Active Motif) according to the
manufacturer’s instructions. Nuclear extract were sonicated to
shear chromatin to a final size of 500–2000 bp and the
supernatant recovered and used directly for immunoprecipitation
experiments by incubation with appropriate antibodies (2 mg) for
1 h at room temperature. The immune complexes were collected
as described above with protein G–Sepharose beads (SIGMA).
After immunoprecipitation, beads were collected and sequentially
washed as described in Caposio et al. [37]. DNA-protein cross-
links were reversed by incubation in 1% SDS/TE buffer at 65uC
overnight. The samples were digested with proteinase K and DNA
was extracted by phenol/chloroform/isoamyl alcohol and then
incubated for 30 min at 37uC TE/RNase A buffer. The input
lysates were processed as above. DNA was analyzed by
quantitative real-time Sybr green PCR using primers for the IR-
1 sequence; the primer sequences used are: forward: 59-
GGTCCTTTGCGACCAGAAT- 39; reverse: 59- TATACTC-
GACAGCGGCGTCT- 39. The amount of the DNA precipitated
by the antibody was normalized to the total input DNA that was
not subjected to immunoprecipitation. The value of 1 was assigned
to the normalized level of IR-1 immunoprecipitated with
unrelated antibody.
Quantitative nucleic acid analysis
Real-time quantitative reverse transcription-PCR (RT-PCR)
analysis was performed on an Mx 3000 P apparatus (Stratagene).
Total RNA was extracted with the NucleoSpin RNA kit
(Macherey-Nagel) and 1 mg was retrotranscribed using the
Revert-Aid H-Minus FirstStrand cDNA Synthesis Kit (Fermentas).
Reverse-transcribed cDNAs were amplified in duplicate using
Brilliant Sybr green QPCR master mix (Fermentas), as described
in Luganini et al. [40] for viral genes or for cellular cytokines [44].
To determine the number of viral DNA genomes per nanogram
of cellular reference DNA (18S rRNA gene), viral DNA levels were
measured by quantitative real-time PCR, as described in Luganini
et al. [40], using the previously reported probe and primers to
amplify a segment of the IE1 gene [46]. HCMV DNA copy
numbers were normalized by dividing by the amount of human
18S rRNA gene (Assay-on- Demand, 18S, assay
no. HS99999901_s1; Applied Biosystems) amplified per reaction
mixture. A standard curve of serially diluted genomic DNA mixed
with an IE1-encoding plasmid (from 10
7 to 1 copy) was created in
parallel with each analysis [47].
In vitro analysis of caspase activities
Caspase 3–7 protease activity was assessed by measuring the
extent of cleavage of a fluorometric peptide substrate using the
SensoLyte AFC Caspase Sampler Kit ‘‘Fluorimetric’’ (Anaspec).
Doxorubicin treatment (0.5 mM for 18 hours) was used for the
positive control. Experiments were performed according to the
manufacturer’s instructions. Fluorescence was measured at an
excitation wavelength of 405 nm and an emission wavelength of
500 nm using the VICTOR
3 1420 multilabel counter (Perkin–
Elmer). Protease activity was expressed as fold induction relative to
the basal level measured in each uninfected cell line.
Statistical analysis
All statistical tests were performed using GraphPad Prism
version 5.00 for Windows (GraphPad Software, San Diego
California USA, www.graphpad.com). The data were presented
as the means 6 standard deviations (SD). Means between two
groups were compared by using a two-tailed t-test.
Means between three groups were compared by using a one-
way or two-way analysis of variance with Bonferroni’s post-test.
Differences were considered statistically significant at p,0.05.
Supporting Information
Figure S1 Assessment of the biological activity of
dominant negative IFI16 (dnIFI16). A) HELFs carrying the
dnIFI16 (DDIFI16 or DBIFI16) or the control LacZ gene were
infected with AdV IFI16 (MOI of 50 PFU/cell). Total RNA was
isolated at 24 hpi and assayed by quantitative real-time PCR to
determine the relative levels of proinflammatory gene transcripts.
Levels of cellular mRNA are presented normalized to the levels of
b-actin. The data shown are the average of three experiments 6
SD (*p,0.05, ** p,0.01, one-way ANOVA followed by
Bonferroni’s post test). B) HELFs carrying the dnIFI16 (DDIFI16
or DBIFI16), the control LacZ gene or left mock infected, were
infected with AdV IFI16 (MOI of 1 to 50 PFU/cell) or treated
with doxorubicin (doxo) as positive control. At 48 hpi, cells were
harvested and equal amounts of cytosolic proteins subjected to a
fluorogenic caspase assay to measure the extent of protease
activity. The extent of cleavage of fluorometric peptide substrate
was assessed, and protease activity was expressed as fold induction
relative to the basal level measured in each uninfected cell line.
The data shown are the average of three experiments 6 SD
(**p,0.01, ***p,0.001 one-way ANOVA followed by Bonferro-
ni’s post test).
(TIF)
Figure S2 Effect of IFI16 silencing on HCMV growth in
endothelial cells. HUVECs were electroporated with a mixture
of four different small interfering RNA (siRNA IFI16) or
scrambled control siRNA (siRNA ctrl) or left not electroporated
(NE), and then infected with VR1814 at an MOI of 1 or 0.1 PFU/
cell. Cell-free supernatants were harvested 96 hours post infection
(hpi) and virus amounts determined by plaque assay. The data
shown are the average of three experiments 6 SD (**p,0.01,
***p,0.001 one-way ANOVA followed by Bonferroni’s post test).
(TIF)
Table S1 Oligonucleotide primer sequences.
(DOC)
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